Euro vs US Dollar

Registrieren Sie sich für Echtzeit-Benachrichtigungen, benutzerdefinierte Portfolios und Marktbewegungen.

Registrieren

ANTX AN2 Therapeutics Inc

2,205

-0,025 (-1,12%)

Zuletzt aktualisiert: 18:17:10

Verzögert um 15 Minuten

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Article too big to display. Click here to view on the SEC website

AN2 Therapeutics (NASDAQ:ANTX)
Historical Stock Chart
Von Apr 2024 bis Mai 2024

Click Here for more AN2 Therapeutics Charts.

AN2 Therapeutics (NASDAQ:ANTX)
Historical Stock Chart
Von Mai 2023 bis Mai 2024

Click Here for more AN2 Therapeutics Charts.

News AN2 Therapeutics Inc

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Dienstag 14 Mai 2024 (7 Tage vor) • Edgar (US Regulatory)

Form 8-K - Current report
Dienstag 14 Mai 2024 (7 Tage vor) • Edgar (US Regulatory)

Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
Dienstag 14 Mai 2024 (7 Tage vor) • Edgar (US Regulatory)

AN2 Therapeutics Reports First Quarter 2024 Financial Results and Recent Business and Scientific Highlights
Dienstag 14 Mai 2024 (7 Tage vor) • Business Wire

AN2 Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Recent Business and Scientific Highlights
Donnerstag 28 März 2024 (2 Monate vor) • Business Wire

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
Dienstag 13 Februar 2024 (3 Monate vor) • Edgar (US Regulatory)

Form 8-K - Current report
Montag 12 Februar 2024 (3 Monate vor) • Edgar (US Regulatory)

AN2 to Voluntarily Pause Enrollment in Phase 3 Part of Phase 2/3 Pivotal Clinical Trial Evaluating Epetraborole for Treatment-Refractory Mycobacterium Avium Complex (MAC) Lung Disease
Montag 12 Februar 2024 (3 Monate vor) • Business Wire

AN2 Therapeutics to Present at Oppenheimer Healthcare Life Sciences Conference
Dienstag 30 Januar 2024 (4 Monate vor) • Business Wire

Form 4 - Statement of changes in beneficial ownership of securities
Freitag 19 Januar 2024 (4 Monate vor) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Mittwoch 17 Januar 2024 (4 Monate vor) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Freitag 12 Januar 2024 (4 Monate vor) • Edgar (US Regulatory)

Weitere AN2 Therapeutics Inc News-Artikel

Euro vs US Dollar

Gold vs US Dollar

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen